These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 20141832)

  • 1. The brothers RAF.
    Kwong LN; Chin L
    Cell; 2010 Jan; 140(2):180-2. PubMed ID: 20141832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-RAF is a therapeutic target in melanoma.
    Karasarides M; Chiloeches A; Hayward R; Niculescu-Duvaz D; Scanlon I; Friedlos F; Ogilvie L; Hedley D; Martin J; Marshall CJ; Springer CJ; Marais R
    Oncogene; 2004 Aug; 23(37):6292-8. PubMed ID: 15208680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAF kinase inhibitors in cancer treatment: like a bull in a China shop?
    Robubi A; Waldmann H; Rauh D
    Chembiochem; 2010 Aug; 11(12):1645-8. PubMed ID: 20648512
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.
    Heidorn SJ; Milagre C; Whittaker S; Nourry A; Niculescu-Duvas I; Dhomen N; Hussain J; Reis-Filho JS; Springer CJ; Pritchard C; Marais R
    Cell; 2010 Jan; 140(2):209-21. PubMed ID: 20141835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs.
    Yeh AH; Bohula EA; Macaulay VM
    Oncogene; 2006 Oct; 25(50):6574-81. PubMed ID: 16715137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relief of inhibitory autophosphorylation activates RAF.
    Cancer Discov; 2013 Jul; 3(7):OF31. PubMed ID: 23847376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On or off target: mutations, models, and predictions.
    Garraway LA; Hahn WC
    Sci Transl Med; 2010 Jun; 2(35):35ps28. PubMed ID: 20538617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.
    Adnane L; Trail PA; Taylor I; Wilhelm SM
    Methods Enzymol; 2006; 407():597-612. PubMed ID: 16757355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
    Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G
    Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-Raf kinase inhibitors for cancer treatment.
    Li N; Batt D; Warmuth M
    Curr Opin Investig Drugs; 2007 Jun; 8(6):452-6. PubMed ID: 17621874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new arms race against melanoma.
    Lejeune FJ
    Melanoma Res; 2006 Feb; 16(1):1-2. PubMed ID: 16432449
    [No Abstract]   [Full Text] [Related]  

  • 12. Is B-Raf a good therapeutic target for melanoma and other malignancies?
    Madhunapantula SV; Robertson GP
    Cancer Res; 2008 Jan; 68(1):5-8. PubMed ID: 18172288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.
    Garnett MJ; Rana S; Paterson H; Barford D; Marais R
    Mol Cell; 2005 Dec; 20(6):963-9. PubMed ID: 16364920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf: a strategic target for therapeutic development against cancer.
    Beeram M; Patnaik A; Rowinsky EK
    J Clin Oncol; 2005 Sep; 23(27):6771-90. PubMed ID: 16170185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer research. Melanoma drug vindicates targeted approach.
    Garber K
    Science; 2009 Dec; 326(5960):1619. PubMed ID: 20019269
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities.
    Kanno N; Lesage G; Phinizy JL; Glaser S; Francis H; Alpini G
    Hepatology; 2002 Jun; 35(6):1329-40. PubMed ID: 12029618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of pyrazolo[1,5-a]pyrimidine-3-carboxylates as B-Raf kinase inhibitors.
    Gopalsamy A; Ciszewski G; Hu Y; Lee F; Feldberg L; Frommer E; Kim S; Collins K; Wojciechowicz D; Mallon R
    Bioorg Med Chem Lett; 2009 May; 19(10):2735-8. PubMed ID: 19362830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fisetin: a natural fist against melanoma?
    Arbiser JL; Fisher DE
    J Invest Dermatol; 2011 Jun; 131(6):1187-9. PubMed ID: 21566577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi-chaperone complex in human epidermoid cancer cells.
    Caraglia M; Marra M; Mancinelli F; D'Ambrosio G; Massa R; Giordano A; Budillon A; Abbruzzese A; Bismuto E
    J Cell Physiol; 2005 Aug; 204(2):539-48. PubMed ID: 15754340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RAF proteins take centre stage.
    Wellbrock C; Karasarides M; Marais R
    Nat Rev Mol Cell Biol; 2004 Nov; 5(11):875-85. PubMed ID: 15520807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.